---
title: "ST SC Pharmaceuticals: Passed the drug GMP compliance inspection"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254582039.md"
description: "ST SC Pharmaceuticals announced that the company recently received the \"Drug GMP Compliance Inspection Notification\" issued by the Hainan Provincial Drug Administration. The inspection scope includes lyophilized powder injections, active pharmaceutical ingredients, and related production lines. The inspection date is from June 11 to 13, 2025, and the inspection conclusion meets the requirements of the Good Manufacturing Practice (GMP) for drug production quality management. This successful inspection indicates that the company's production quality management system complies with the requirements of the Good Manufacturing Practice for drug production, which is beneficial for maintaining stable production capacity and meeting market demand"
datetime: "2025-08-26T09:00:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254582039.md)
  - [en](https://longbridge.com/en/news/254582039.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254582039.md)
generator: "portal-rs"
---

# ST SC Pharmaceuticals: Passed the drug GMP compliance inspection

\*ST SC Pharmaceuticals announced that the company recently received the "Drug GMP Compliance Inspection Notification" approved by the Hainan Provincial Drug Administration. The inspection scope includes lyophilized powder injections, active pharmaceutical ingredients, and related production lines. The inspection date is from June 11 to June 13, 2025, and the inspection conclusion meets the requirements of the Good Manufacturing Practice for drug production. This successful inspection indicates that the company's production quality management system complies with the requirements of the Good Manufacturing Practice for drug production, which is beneficial for maintaining stable production capacity and meeting market demand

### Related Stocks

- [002693.CN](https://longbridge.com/en/quote/002693.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [17:00 ETCulture Amp Adds Missing Context to AI, Infusing Culture Intelligence Directly Inside the Tools Leaders Use Daily](https://longbridge.com/en/news/296828906.md)
- [YMTC's STAR Mkt IPO Application Accepted, w/ Plans to Raise RMB33B](https://longbridge.com/en/news/296724109.md)
- [13:45 ETEdimakor V5.2.0 Integrates DeepSeek V4 for AI Story and Elevates AI Avatars with New Templates](https://longbridge.com/en/news/296817622.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**